Podocarpusflavone B

Podocarpusflavone B

SCHEMBL29496271

COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4O)c3o2)cc1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.73
▸ MEN1 O00255 3/20 0.73
▸ KMT2A Q03164 3/20 0.73
▸ USP2 O75604 2/20 0.73
▸ TP53 P04637 2/20 0.73
▸ KDM4E B2RXH2 1/20 0.73
▸ HPGD P15428 1/20 0.73
▸ ALOX15 P16050 1/20 0.73
▸ HBB P68871 1/20 0.73
▸ HSD17B10 Q99714 1/20 0.73
▸ MAOB P27338 2/20 0.71
▸ CYP19A1 P11511 1/20 0.71
▸ APP P05067 5/20 0.69
▸ FLT3 P36888 2/20 0.65
▸ IP6K2 Q9UHH9 2/20 0.65
▸ NPC1 O15118 2/20 0.65
▸ CYP3A4 P08684 2/20 0.65
▸ CYP2C9 P11712 2/20 0.65
▸ CYP2C19 P33261 2/20 0.65
▸ TDP1 Q9NUW8 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Podocarpusflavone B SCHEMBL27350627 1.00 MAPT (0.73) MAPTMEN1KMT2AUSP2TP53
Podocarpusflavone A SCHEMBL25937932 0.96 MEN1 (0.72) MAPTMEN1KMT2AUSP2TP53
Podocarpusflavone A SCHEMBL29496316 0.96 MEN1 (0.72) MAPTMEN1KMT2AUSP2TP53
Sequoiaflavone SCHEMBL1158361 0.96 MEN1 (0.73) MAPTMEN1KMT2AUSP2TP53
Sequoiaflavone SCHEMBL30646160 0.96 MEN1 (0.73) MAPTMEN1KMT2AUSP2TP53
Heveaflavone SCHEMBL30646163 0.92 APP (0.72) MAPTMEN1KMT2AUSP2TP53
Sciadopitisin SCHEMBL30996894 0.92 MAPT (0.86) MAPTMEN1KMT2AUSP2TP53
Heveaflavone SCHEMBL27350698 0.92 APP (0.72) MAPTMEN1KMT2AUSP2TP53
Sciadopitisin SCHEMBL1158050 0.92 MAPT (0.86) MAPTMEN1KMT2AUSP2TP53
7'',4'''-Dimethylamentoflavone SCHEMBL30646161 0.88 APP (0.72) MAPTMEN1KMT2AUSP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3498297-B1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM STALICLA S A (CH) 2023-06-21 — — EP disclosed
US-11439627-B2 Pharmaceutical composition for the treatment of autism Stalicla S.A. (CH) 2022-09-13 — — US disclosed
EP-3984555-A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM Stalicla S.A. (CH) 2022-04-20 — — EP disclosed
Send feedback